Here are the major moves the Trump Administration has made so far affecting reproductive healthcare access.
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Federal judges rule that President Donald Trump can't direct the government to stop funding grotesque transgender "medicine." ...
BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today ...
Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...
On Wednesday night Judge Amir H. Ali of the U.S. District Court for the District of Columbia denied a motion to hold the ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
Department of Health and Human Services protested outside the agency’s headquarters in Washington, D.C. As ABC News’s Hannah ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback